Unknown PHASE3 INTERVENTIONAL 2-arm NCT04872322

Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery

Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery

Sponsor: Rothman Institute Orthopaedics

Conditions Ankle Surgery Foot Surgery Popliteal Nerve Block

Interventions Foot/Ankle Surgery Norco Pill Percocet Pill Ropivacaine 0.25% Injectable Solution Ropivacaine 0.5% Injectable Solution

Updated 4 times since 2021 Last updated: May 3, 2021 Started: Aug 31, 2017 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Ankle Surgery and Foot Surgery, this trial is ongoing. The trial is conducted by Rothman Institute Orthopaedics and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jun 2023 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Enrolling By Invitation → Unknown Status
Jun 2021 — Jun 2023 [monthly]

Enrolling By Invitation PHASE3

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rothman Institute Orthopaedics

Data source: Rothman Institute Orthopaedics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States